nodes	percent_of_prediction	percent_of_DWPC	metapath
Proguanil—DHFR—Methotrexate—colon cancer	0.633	0.67	CbGbCtD
Proguanil—CYP2C9—Capecitabine—colon cancer	0.107	0.113	CbGbCtD
Proguanil—CYP1A2—Fluorouracil—colon cancer	0.0702	0.0743	CbGbCtD
Proguanil—CYP2C9—Fluorouracil—colon cancer	0.0632	0.067	CbGbCtD
Proguanil—CYP3A4—Irinotecan—colon cancer	0.0383	0.0406	CbGbCtD
Proguanil—CYP3A4—Vincristine—colon cancer	0.0335	0.0355	CbGbCtD
Proguanil—Pancytopenia—Vincristine—colon cancer	0.000884	0.0232	CcSEcCtD
Proguanil—Pancytopenia—Fluorouracil—colon cancer	0.000825	0.0216	CcSEcCtD
Proguanil—Stomatitis—Vincristine—colon cancer	0.000809	0.0212	CcSEcCtD
Proguanil—Stomatitis—Irinotecan—colon cancer	0.000788	0.0207	CcSEcCtD
Proguanil—Hepatic enzyme increased—Methotrexate—colon cancer	0.000761	0.02	CcSEcCtD
Proguanil—DHFR—G1/S-Specific Transcription—TYMS—colon cancer	0.000761	0.0606	CbGpPWpGaD
Proguanil—Stomatitis—Fluorouracil—colon cancer	0.000755	0.0198	CcSEcCtD
Proguanil—Hallucination—Vincristine—colon cancer	0.000741	0.0195	CcSEcCtD
Proguanil—Mediastinal disorder—Vincristine—colon cancer	0.000672	0.0176	CcSEcCtD
Proguanil—Immune system disorder—Irinotecan—colon cancer	0.000655	0.0172	CcSEcCtD
Proguanil—Mediastinal disorder—Irinotecan—colon cancer	0.000654	0.0172	CcSEcCtD
Proguanil—Mental disorder—Vincristine—colon cancer	0.000653	0.0171	CcSEcCtD
Proguanil—Erythema—Fluorouracil—colon cancer	0.000605	0.0159	CcSEcCtD
Proguanil—Pancytopenia—Capecitabine—colon cancer	0.000576	0.0151	CcSEcCtD
Proguanil—Cough—Irinotecan—colon cancer	0.000551	0.0145	CcSEcCtD
Proguanil—DHFR—embryo—colon cancer	0.000528	0.106	CbGeAlD
Proguanil—Stomatitis—Capecitabine—colon cancer	0.000527	0.0138	CcSEcCtD
Proguanil—Nervous system disorder—Vincristine—colon cancer	0.000519	0.0136	CcSEcCtD
Proguanil—Hepatobiliary disease—Capecitabine—colon cancer	0.000512	0.0134	CcSEcCtD
Proguanil—DHFR—One Carbon Metabolism—TYMS—colon cancer	0.00051	0.0407	CbGpPWpGaD
Proguanil—Nervous system disorder—Irinotecan—colon cancer	0.000506	0.0133	CcSEcCtD
Proguanil—Anorexia—Vincristine—colon cancer	0.000505	0.0132	CcSEcCtD
Proguanil—Anorexia—Irinotecan—colon cancer	0.000491	0.0129	CcSEcCtD
Proguanil—Nervous system disorder—Fluorouracil—colon cancer	0.000484	0.0127	CcSEcCtD
Proguanil—Anorexia—Fluorouracil—colon cancer	0.000471	0.0124	CcSEcCtD
Proguanil—Decreased appetite—Vincristine—colon cancer	0.00046	0.0121	CcSEcCtD
Proguanil—DHFR—Trans-sulfuration and one carbon metabolism—TYMS—colon cancer	0.000459	0.0365	CbGpPWpGaD
Proguanil—Gastrointestinal disorder—Vincristine—colon cancer	0.000457	0.012	CcSEcCtD
Proguanil—Decreased appetite—Irinotecan—colon cancer	0.000448	0.0118	CcSEcCtD
Proguanil—DHFR—Fluoropyrimidine Activity—TYMS—colon cancer	0.000447	0.0357	CbGpPWpGaD
Proguanil—DHFR—E2F mediated regulation of DNA replication—TYMS—colon cancer	0.000447	0.0357	CbGpPWpGaD
Proguanil—Gastrointestinal disorder—Irinotecan—colon cancer	0.000445	0.0117	CcSEcCtD
Proguanil—Immune system disorder—Capecitabine—colon cancer	0.000439	0.0115	CcSEcCtD
Proguanil—Mediastinal disorder—Capecitabine—colon cancer	0.000438	0.0115	CcSEcCtD
Proguanil—Gastrointestinal pain—Vincristine—colon cancer	0.000433	0.0114	CcSEcCtD
Proguanil—DHFR—Retinoblastoma (RB) in Cancer—MSH6—colon cancer	0.000432	0.0344	CbGpPWpGaD
Proguanil—Decreased appetite—Fluorouracil—colon cancer	0.000429	0.0113	CcSEcCtD
Proguanil—Pancytopenia—Methotrexate—colon cancer	0.000429	0.0113	CcSEcCtD
Proguanil—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000426	0.0112	CcSEcCtD
Proguanil—Mental disorder—Capecitabine—colon cancer	0.000426	0.0112	CcSEcCtD
Proguanil—Erythema—Capecitabine—colon cancer	0.000423	0.0111	CcSEcCtD
Proguanil—Malnutrition—Capecitabine—colon cancer	0.000423	0.0111	CcSEcCtD
Proguanil—Gastrointestinal pain—Irinotecan—colon cancer	0.000422	0.0111	CcSEcCtD
Proguanil—Abdominal pain—Vincristine—colon cancer	0.000418	0.011	CcSEcCtD
Proguanil—Body temperature increased—Vincristine—colon cancer	0.000418	0.011	CcSEcCtD
Proguanil—Abdominal pain—Irinotecan—colon cancer	0.000408	0.0107	CcSEcCtD
Proguanil—Body temperature increased—Irinotecan—colon cancer	0.000408	0.0107	CcSEcCtD
Proguanil—DHFR—renal system—colon cancer	0.0004	0.08	CbGeAlD
Proguanil—Stomatitis—Methotrexate—colon cancer	0.000393	0.0103	CcSEcCtD
Proguanil—Body temperature increased—Fluorouracil—colon cancer	0.00039	0.0102	CcSEcCtD
Proguanil—Hepatobiliary disease—Methotrexate—colon cancer	0.000381	0.01	CcSEcCtD
Proguanil—Cough—Capecitabine—colon cancer	0.000369	0.00968	CcSEcCtD
Proguanil—Diarrhoea—Vincristine—colon cancer	0.000362	0.00951	CcSEcCtD
Proguanil—CYP2D6—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000359	0.0286	CbGpPWpGaD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000357	0.00938	CcSEcCtD
Proguanil—CYP2E1—Metapathway biotransformation—CHST4—colon cancer	0.000353	0.0282	CbGpPWpGaD
Proguanil—Diarrhoea—Irinotecan—colon cancer	0.000353	0.00926	CcSEcCtD
Proguanil—Nervous system disorder—Capecitabine—colon cancer	0.000338	0.00888	CcSEcCtD
Proguanil—Diarrhoea—Fluorouracil—colon cancer	0.000338	0.00887	CcSEcCtD
Proguanil—Vomiting—Vincristine—colon cancer	0.000337	0.00884	CcSEcCtD
Proguanil—Skin disorder—Capecitabine—colon cancer	0.000335	0.0088	CcSEcCtD
Proguanil—Rash—Vincristine—colon cancer	0.000334	0.00876	CcSEcCtD
Proguanil—Dermatitis—Vincristine—colon cancer	0.000333	0.00875	CcSEcCtD
Proguanil—DHFR—lymphoid tissue—colon cancer	0.000332	0.0664	CbGeAlD
Proguanil—Headache—Vincristine—colon cancer	0.000332	0.00871	CcSEcCtD
Proguanil—Anorexia—Capecitabine—colon cancer	0.000329	0.00863	CcSEcCtD
Proguanil—Vomiting—Irinotecan—colon cancer	0.000328	0.0086	CcSEcCtD
Proguanil—DHFR—digestive system—colon cancer	0.000328	0.0656	CbGeAlD
Proguanil—Immune system disorder—Methotrexate—colon cancer	0.000327	0.00857	CcSEcCtD
Proguanil—Mediastinal disorder—Methotrexate—colon cancer	0.000326	0.00855	CcSEcCtD
Proguanil—Rash—Irinotecan—colon cancer	0.000325	0.00853	CcSEcCtD
Proguanil—Dermatitis—Irinotecan—colon cancer	0.000325	0.00852	CcSEcCtD
Proguanil—Headache—Irinotecan—colon cancer	0.000323	0.00848	CcSEcCtD
Proguanil—Mental disorder—Methotrexate—colon cancer	0.000317	0.00831	CcSEcCtD
Proguanil—Erythema—Methotrexate—colon cancer	0.000315	0.00826	CcSEcCtD
Proguanil—Malnutrition—Methotrexate—colon cancer	0.000315	0.00826	CcSEcCtD
Proguanil—Nausea—Vincristine—colon cancer	0.000314	0.00825	CcSEcCtD
Proguanil—Vomiting—Fluorouracil—colon cancer	0.000314	0.00824	CcSEcCtD
Proguanil—Rash—Fluorouracil—colon cancer	0.000311	0.00817	CcSEcCtD
Proguanil—Dermatitis—Fluorouracil—colon cancer	0.000311	0.00816	CcSEcCtD
Proguanil—Headache—Fluorouracil—colon cancer	0.000309	0.00812	CcSEcCtD
Proguanil—Nausea—Irinotecan—colon cancer	0.000306	0.00804	CcSEcCtD
Proguanil—DHFR—bone marrow—colon cancer	0.000302	0.0605	CbGeAlD
Proguanil—Decreased appetite—Capecitabine—colon cancer	0.0003	0.00787	CcSEcCtD
Proguanil—Gastrointestinal disorder—Capecitabine—colon cancer	0.000298	0.00782	CcSEcCtD
Proguanil—Nausea—Fluorouracil—colon cancer	0.000293	0.0077	CcSEcCtD
Proguanil—DHFR—vagina—colon cancer	0.000289	0.0579	CbGeAlD
Proguanil—Gastrointestinal pain—Capecitabine—colon cancer	0.000282	0.00741	CcSEcCtD
Proguanil—DHFR—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—AKT1—colon cancer	0.000281	0.0224	CbGpPWpGaD
Proguanil—Cough—Methotrexate—colon cancer	0.000275	0.00721	CcSEcCtD
Proguanil—Abdominal pain—Capecitabine—colon cancer	0.000273	0.00716	CcSEcCtD
Proguanil—Body temperature increased—Capecitabine—colon cancer	0.000273	0.00716	CcSEcCtD
Proguanil—CYP2C19—Metapathway biotransformation—CHST4—colon cancer	0.000273	0.0217	CbGpPWpGaD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000266	0.00698	CcSEcCtD
Proguanil—Nervous system disorder—Methotrexate—colon cancer	0.000252	0.00661	CcSEcCtD
Proguanil—CYP2D6—Metapathway biotransformation—CHST4—colon cancer	0.000251	0.02	CbGpPWpGaD
Proguanil—Skin disorder—Methotrexate—colon cancer	0.00025	0.00655	CcSEcCtD
Proguanil—CYP2C9—Metapathway biotransformation—CHST4—colon cancer	0.000249	0.0198	CbGpPWpGaD
Proguanil—Anorexia—Methotrexate—colon cancer	0.000245	0.00643	CcSEcCtD
Proguanil—DHFR—liver—colon cancer	0.000244	0.0489	CbGeAlD
Proguanil—DHFR—E2F transcription factor network—TYMS—colon cancer	0.000237	0.0189	CbGpPWpGaD
Proguanil—Diarrhoea—Capecitabine—colon cancer	0.000236	0.0062	CcSEcCtD
Proguanil—CYP3A4—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000235	0.0187	CbGpPWpGaD
Proguanil—Decreased appetite—Methotrexate—colon cancer	0.000223	0.00586	CcSEcCtD
Proguanil—Gastrointestinal disorder—Methotrexate—colon cancer	0.000222	0.00582	CcSEcCtD
Proguanil—Vomiting—Capecitabine—colon cancer	0.000219	0.00576	CcSEcCtD
Proguanil—Rash—Capecitabine—colon cancer	0.000218	0.00571	CcSEcCtD
Proguanil—Dermatitis—Capecitabine—colon cancer	0.000217	0.00571	CcSEcCtD
Proguanil—Headache—Capecitabine—colon cancer	0.000216	0.00567	CcSEcCtD
Proguanil—CYP1A2—Metapathway biotransformation—CHST4—colon cancer	0.000212	0.0169	CbGpPWpGaD
Proguanil—Gastrointestinal pain—Methotrexate—colon cancer	0.00021	0.00551	CcSEcCtD
Proguanil—DHFR—Retinoblastoma (RB) in Cancer—TYMS—colon cancer	0.000206	0.0164	CbGpPWpGaD
Proguanil—Nausea—Capecitabine—colon cancer	0.000205	0.00538	CcSEcCtD
Proguanil—Body temperature increased—Methotrexate—colon cancer	0.000203	0.00533	CcSEcCtD
Proguanil—Abdominal pain—Methotrexate—colon cancer	0.000203	0.00533	CcSEcCtD
Proguanil—DHFR—Metabolism of nitric oxide—AKT1—colon cancer	0.000195	0.0155	CbGpPWpGaD
Proguanil—DHFR—lymph node—colon cancer	0.000187	0.0375	CbGeAlD
Proguanil—CYP2C19—digestive system—colon cancer	0.000186	0.0373	CbGeAlD
Proguanil—CYP1A2—renal system—colon cancer	0.000186	0.0371	CbGeAlD
Proguanil—Diarrhoea—Methotrexate—colon cancer	0.000176	0.00461	CcSEcCtD
Proguanil—DHFR—G1/S Transition—TYMS—colon cancer	0.000172	0.0137	CbGpPWpGaD
Proguanil—CYP2E1—renal system—colon cancer	0.000167	0.0334	CbGeAlD
Proguanil—DHFR—Cell Cycle—MLH3—colon cancer	0.000166	0.0132	CbGpPWpGaD
Proguanil—CYP2C19—vagina—colon cancer	0.000165	0.0329	CbGeAlD
Proguanil—CYP3A4—Metapathway biotransformation—CHST4—colon cancer	0.000164	0.0131	CbGpPWpGaD
Proguanil—Vomiting—Methotrexate—colon cancer	0.000163	0.00429	CcSEcCtD
Proguanil—CYP2E1—Metapathway biotransformation—CHST5—colon cancer	0.000162	0.0129	CbGpPWpGaD
Proguanil—Rash—Methotrexate—colon cancer	0.000162	0.00425	CcSEcCtD
Proguanil—Dermatitis—Methotrexate—colon cancer	0.000162	0.00425	CcSEcCtD
Proguanil—Headache—Methotrexate—colon cancer	0.000161	0.00422	CcSEcCtD
Proguanil—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000159	0.0127	CbGpPWpGaD
Proguanil—Nausea—Methotrexate—colon cancer	0.000153	0.004	CcSEcCtD
Proguanil—CYP1A2—digestive system—colon cancer	0.000152	0.0305	CbGeAlD
Proguanil—DHFR—Fluoropyrimidine Activity—TP53—colon cancer	0.000148	0.0118	CbGpPWpGaD
Proguanil—DHFR—Mitotic G1-G1/S phases—TYMS—colon cancer	0.000145	0.0116	CbGpPWpGaD
Proguanil—CYP2C9—digestive system—colon cancer	0.000145	0.0289	CbGeAlD
Proguanil—CYP2C19—liver—colon cancer	0.000139	0.0278	CbGeAlD
Proguanil—CYP2E1—lymphoid tissue—colon cancer	0.000139	0.0277	CbGeAlD
Proguanil—CYP2E1—digestive system—colon cancer	0.000137	0.0274	CbGeAlD
Proguanil—CYP3A4—renal system—colon cancer	0.000134	0.0269	CbGeAlD
Proguanil—CYP2D6—renal system—colon cancer	0.000132	0.0265	CbGeAlD
Proguanil—DHFR—Metabolism—CA7—colon cancer	0.00013	0.0104	CbGpPWpGaD
Proguanil—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000129	0.0103	CbGpPWpGaD
Proguanil—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000128	0.0102	CbGpPWpGaD
Proguanil—CYP2C19—Metapathway biotransformation—CHST5—colon cancer	0.000125	0.00998	CbGpPWpGaD
Proguanil—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000117	0.00936	CbGpPWpGaD
Proguanil—DHFR—E2F transcription factor network—CDKN1A—colon cancer	0.000115	0.0092	CbGpPWpGaD
Proguanil—CYP2D6—Metapathway biotransformation—CHST5—colon cancer	0.000115	0.00918	CbGpPWpGaD
Proguanil—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—colon cancer	0.000115	0.00915	CbGpPWpGaD
Proguanil—CYP2C9—Metapathway biotransformation—CHST5—colon cancer	0.000114	0.0091	CbGpPWpGaD
Proguanil—CYP1A2—liver—colon cancer	0.000113	0.0227	CbGeAlD
Proguanil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000112	0.00892	CbGpPWpGaD
Proguanil—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000111	0.00882	CbGpPWpGaD
Proguanil—CYP3A4—digestive system—colon cancer	0.00011	0.0221	CbGeAlD
Proguanil—DHFR—E2F transcription factor network—EP300—colon cancer	0.00011	0.00876	CbGpPWpGaD
Proguanil—CYP2D6—digestive system—colon cancer	0.000108	0.0217	CbGeAlD
Proguanil—CYP3A4—Irinotecan Pathway—APC—colon cancer	0.000108	0.00862	CbGpPWpGaD
Proguanil—CYP2C9—liver—colon cancer	0.000108	0.0215	CbGeAlD
Proguanil—DHFR—Retinoblastoma (RB) in Cancer—CCND1—colon cancer	0.000104	0.00827	CbGpPWpGaD
Proguanil—CYP2E1—liver—colon cancer	0.000102	0.0204	CbGeAlD
Proguanil—DHFR—Retinoblastoma (RB) in Cancer—CDKN1A—colon cancer	0.0001	0.008	CbGpPWpGaD
Proguanil—CYP1A2—Metapathway biotransformation—CHST5—colon cancer	9.75e-05	0.00777	CbGpPWpGaD
Proguanil—DHFR—E2F transcription factor network—MYC—colon cancer	9.57e-05	0.00763	CbGpPWpGaD
Proguanil—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	9.56e-05	0.00762	CbGpPWpGaD
Proguanil—DHFR—Disease—CHST5—colon cancer	9.4e-05	0.00749	CbGpPWpGaD
Proguanil—DHFR—Disease—LGR5—colon cancer	9.4e-05	0.00749	CbGpPWpGaD
Proguanil—DHFR—Folate Metabolism—TP53—colon cancer	8.52e-05	0.00679	CbGpPWpGaD
Proguanil—DHFR—G1/S Transition—CDKN1A—colon cancer	8.38e-05	0.00668	CbGpPWpGaD
Proguanil—DHFR—Retinoblastoma (RB) in Cancer—MYC—colon cancer	8.32e-05	0.00663	CbGpPWpGaD
Proguanil—CYP3A4—liver—colon cancer	8.21e-05	0.0164	CbGeAlD
Proguanil—CYP2D6—liver—colon cancer	8.08e-05	0.0162	CbGeAlD
Proguanil—DHFR—Metabolism—CHST5—colon cancer	7.87e-05	0.00627	CbGpPWpGaD
Proguanil—DHFR—Metabolism—ODC1—colon cancer	7.87e-05	0.00627	CbGpPWpGaD
Proguanil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	7.78e-05	0.0062	CbGpPWpGaD
Proguanil—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	7.74e-05	0.00617	CbGpPWpGaD
Proguanil—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	7.53e-05	0.006	CbGpPWpGaD
Proguanil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	7.38e-05	0.00588	CbGpPWpGaD
Proguanil—DHFR—Mitotic G1-G1/S phases—CCND1—colon cancer	7.3e-05	0.00582	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—MLH1—colon cancer	7.29e-05	0.00581	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—colon cancer	7.1e-05	0.00566	CbGpPWpGaD
Proguanil—DHFR—Mitotic G1-G1/S phases—CDKN1A—colon cancer	7.06e-05	0.00563	CbGpPWpGaD
Proguanil—DHFR—G1/S Transition—MYC—colon cancer	6.95e-05	0.00554	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—BUB1B—colon cancer	6.93e-05	0.00553	CbGpPWpGaD
Proguanil—DHFR—Retinoblastoma (RB) in Cancer—TP53—colon cancer	6.83e-05	0.00545	CbGpPWpGaD
Proguanil—DHFR—Disease—AXIN2—colon cancer	6.75e-05	0.00538	CbGpPWpGaD
Proguanil—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	6.65e-05	0.0053	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—BUB1B—colon cancer	6.2e-05	0.00494	CbGpPWpGaD
Proguanil—DHFR—Mitotic G1-G1/S phases—MYC—colon cancer	5.85e-05	0.00467	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—TYMS—colon cancer	5.32e-05	0.00424	CbGpPWpGaD
Proguanil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	5.13e-05	0.00409	CbGpPWpGaD
Proguanil—CYP2C19—Arachidonic acid metabolism—PTGS2—colon cancer	4.93e-05	0.00393	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—TYMS—colon cancer	4.75e-05	0.00379	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CA7—colon cancer	4.64e-05	0.0037	CbGpPWpGaD
Proguanil—CYP2C9—Arachidonic acid metabolism—PTGS2—colon cancer	4.5e-05	0.00358	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	4.11e-05	0.00327	CbGpPWpGaD
Proguanil—CYP1A2—Arachidonic acid metabolism—PTGS2—colon cancer	3.84e-05	0.00306	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	3.59e-05	0.00286	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CA7—colon cancer	3.58e-05	0.00286	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	3.42e-05	0.00272	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—EP300—colon cancer	3.42e-05	0.00272	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	3.32e-05	0.00265	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—SRC—colon cancer	3.32e-05	0.00265	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CA7—colon cancer	3.3e-05	0.00263	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CA7—colon cancer	3.27e-05	0.0026	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	3.24e-05	0.00258	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—colon cancer	3.2e-05	0.00255	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—MYC—colon cancer	2.98e-05	0.00237	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	2.97e-05	0.00237	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	2.91e-05	0.00232	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	2.91e-05	0.00232	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CHST5—colon cancer	2.81e-05	0.00224	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—ODC1—colon cancer	2.81e-05	0.00224	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CA7—colon cancer	2.79e-05	0.00222	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	2.75e-05	0.00219	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—CCND1—colon cancer	2.68e-05	0.00213	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—CDKN1A—colon cancer	2.59e-05	0.00206	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—EP300—colon cancer	2.46e-05	0.00196	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—CCND1—colon cancer	2.39e-05	0.00191	CbGpPWpGaD
Proguanil—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	2.34e-05	0.00186	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—CDKN1A—colon cancer	2.32e-05	0.00185	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—EP300—colon cancer	2.2e-05	0.00176	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CHST5—colon cancer	2.17e-05	0.00173	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ODC1—colon cancer	2.17e-05	0.00173	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CA7—colon cancer	2.15e-05	0.00172	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle, Mitotic—MYC—colon cancer	2.15e-05	0.00171	CbGpPWpGaD
Proguanil—DHFR—Metabolism—ABCB1—colon cancer	2.08e-05	0.00166	CbGpPWpGaD
Proguanil—DHFR—Metabolism—TYMS—colon cancer	2.04e-05	0.00163	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CHST5—colon cancer	2e-05	0.00159	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ODC1—colon cancer	2e-05	0.00159	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ODC1—colon cancer	1.98e-05	0.00158	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CHST5—colon cancer	1.98e-05	0.00158	CbGpPWpGaD
Proguanil—DHFR—Disease—FGFR3—colon cancer	1.95e-05	0.00155	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—MYC—colon cancer	1.92e-05	0.00153	CbGpPWpGaD
Proguanil—DHFR—Disease—APC—colon cancer	1.79e-05	0.00143	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CHST5—colon cancer	1.69e-05	0.00135	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ODC1—colon cancer	1.69e-05	0.00135	CbGpPWpGaD
Proguanil—DHFR—Disease—BRAF—colon cancer	1.68e-05	0.00134	CbGpPWpGaD
Proguanil—DHFR—Cell Cycle—TP53—colon cancer	1.58e-05	0.00126	CbGpPWpGaD
Proguanil—DHFR—Metabolism—PPARG—colon cancer	1.45e-05	0.00115	CbGpPWpGaD
Proguanil—DHFR—Disease—PTGS2—colon cancer	1.36e-05	0.00108	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ODC1—colon cancer	1.31e-05	0.00104	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CHST5—colon cancer	1.31e-05	0.00104	CbGpPWpGaD
Proguanil—DHFR—Disease—CTNNB1—colon cancer	1.22e-05	0.000969	CbGpPWpGaD
Proguanil—DHFR—Disease—CDKN1A—colon cancer	1.19e-05	0.000947	CbGpPWpGaD
Proguanil—DHFR—Metabolism—PTGS2—colon cancer	1.14e-05	0.000907	CbGpPWpGaD
Proguanil—DHFR—Disease—EP300—colon cancer	1.13e-05	0.000901	CbGpPWpGaD
Proguanil—DHFR—Disease—SRC—colon cancer	1.1e-05	0.000876	CbGpPWpGaD
Proguanil—DHFR—Disease—NRAS—colon cancer	1.06e-05	0.000843	CbGpPWpGaD
Proguanil—DHFR—Disease—MYC—colon cancer	9.85e-06	0.000785	CbGpPWpGaD
Proguanil—DHFR—Disease—TGFB1—colon cancer	9.82e-06	0.000783	CbGpPWpGaD
Proguanil—DHFR—Disease—EGFR—colon cancer	9.63e-06	0.000768	CbGpPWpGaD
Proguanil—DHFR—Metabolism—EP300—colon cancer	9.46e-06	0.000754	CbGpPWpGaD
Proguanil—DHFR—Disease—KRAS—colon cancer	9.1e-06	0.000725	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	8.96e-06	0.000714	CbGpPWpGaD
Proguanil—DHFR—Disease—PIK3CA—colon cancer	8.36e-06	0.000666	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	8.17e-06	0.000651	CbGpPWpGaD
Proguanil—DHFR—Disease—HRAS—colon cancer	7.73e-06	0.000616	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—ABCB1—colon cancer	7.43e-06	0.000592	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—TYMS—colon cancer	7.3e-06	0.000582	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.05e-06	0.000562	CbGpPWpGaD
Proguanil—DHFR—Metabolism—PIK3CA—colon cancer	7e-06	0.000558	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	6.98e-06	0.000556	CbGpPWpGaD
Proguanil—DHFR—Disease—AKT1—colon cancer	6.83e-06	0.000544	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.43e-06	0.000512	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.86e-06	0.000467	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ABCB1—colon cancer	5.74e-06	0.000457	CbGpPWpGaD
Proguanil—DHFR—Metabolism—AKT1—colon cancer	5.72e-06	0.000456	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—TYMS—colon cancer	5.63e-06	0.000449	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	5.49e-06	0.000438	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.35e-06	0.000426	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ABCB1—colon cancer	5.28e-06	0.00042	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ABCB1—colon cancer	5.23e-06	0.000417	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—TYMS—colon cancer	5.18e-06	0.000413	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PPARG—colon cancer	5.17e-06	0.000412	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—TYMS—colon cancer	5.14e-06	0.000409	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.57e-06	0.000364	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ABCB1—colon cancer	4.47e-06	0.000356	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—TYMS—colon cancer	4.39e-06	0.00035	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.34e-06	0.000346	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PTGS2—colon cancer	4.07e-06	0.000324	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PPARG—colon cancer	3.99e-06	0.000318	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.95e-06	0.000315	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PPARG—colon cancer	3.67e-06	0.000293	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PPARG—colon cancer	3.64e-06	0.00029	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ABCB1—colon cancer	3.45e-06	0.000275	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—TYMS—colon cancer	3.39e-06	0.00027	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—EP300—colon cancer	3.38e-06	0.00027	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.38e-06	0.000269	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PTGS2—colon cancer	3.14e-06	0.00025	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PPARG—colon cancer	3.11e-06	0.000248	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PTGS2—colon cancer	2.89e-06	0.00023	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PTGS2—colon cancer	2.86e-06	0.000228	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—EP300—colon cancer	2.61e-06	0.000208	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PIK3CA—colon cancer	2.5e-06	0.0002	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PTGS2—colon cancer	2.45e-06	0.000195	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—EP300—colon cancer	2.4e-06	0.000191	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PPARG—colon cancer	2.4e-06	0.000191	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—EP300—colon cancer	2.38e-06	0.00019	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—AKT1—colon cancer	2.04e-06	0.000163	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—EP300—colon cancer	2.03e-06	0.000162	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PIK3CA—colon cancer	1.93e-06	0.000154	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PTGS2—colon cancer	1.89e-06	0.00015	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PIK3CA—colon cancer	1.78e-06	0.000142	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PIK3CA—colon cancer	1.76e-06	0.00014	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—AKT1—colon cancer	1.58e-06	0.000126	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—EP300—colon cancer	1.57e-06	0.000125	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PIK3CA—colon cancer	1.5e-06	0.00012	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—AKT1—colon cancer	1.45e-06	0.000116	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—AKT1—colon cancer	1.44e-06	0.000115	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—AKT1—colon cancer	1.23e-06	9.8e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PIK3CA—colon cancer	1.16e-06	9.26e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—AKT1—colon cancer	9.49e-07	7.56e-05	CbGpPWpGaD
